These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 406989
1. Metabolic reduction of 4-nitroquinoline N-oxide and other radical-producing drugs to oxygen-reactive intermediates. Biaglow JE, Jacobson BE, Nygaard OF. Cancer Res; 1977 Sep; 37(9):3306-13. PubMed ID: 406989 [No Abstract] [Full Text] [Related]
2. Interactions of the carcinogen 4-nitroquinoline 1-oxide with the non-protein thiols of mammalian cells. Varnes ME, Biaglow JE. Cancer Res; 1979 Aug; 39(8):2960-5. PubMed ID: 110443 [Abstract] [Full Text] [Related]
3. Electron transfer in Ehrlich ascites tumor cells in the presence of nitrofurans. Biaglow JE, Nygaard OF, Greenstock CL. Biochem Pharmacol; 1976 Feb 15; 25(4):393-8. PubMed ID: 180998 [No Abstract] [Full Text] [Related]
4. [Mechanism of the trypanocidal action of nifurtimox and other nitro-derivatives on Trypanosoma cruzi]. Docampo R, Stoppani AO. Medicina (B Aires); 1980 Feb 15; 40 Suppl 1():10-6. PubMed ID: 6779074 [No Abstract] [Full Text] [Related]
6. Intracellular hydrogen transport in Ehrlich ascites tumor cells. Gordon EE, Ernster L, Dallner G. Cancer Res; 1967 Aug 15; 27(8):1372-7. PubMed ID: 4963325 [No Abstract] [Full Text] [Related]
8. Metabolism of 4-nitroquinoline 1-oxide and related compounds. Tada M. Carcinog Compr Surv; 1981 Aug 15; 6():25-45. PubMed ID: 6786744 [No Abstract] [Full Text] [Related]
9. [Enhancement of reduction activity of 4-nitroquinoline N-oxide in rats pretreated with 3-methylcholanthrene-type PCB]. Yoshimura H, Koga N, Wada I, Hokama Y, Kuroki J. Fukuoka Igaku Zasshi; 1983 May 15; 74(5):217-21. PubMed ID: 6411563 [No Abstract] [Full Text] [Related]
12. Glutamine and glucose as energy substrates for Ehrlich ascites tumour cells. Medina MA, Sánchez-Jiménez F, Márquez FJ, Pérez-Rodríguez J, Quesada AR, Núñez de Castro I. Biochem Int; 1988 Feb 15; 16(2):339-47. PubMed ID: 3365266 [Abstract] [Full Text] [Related]
13. The reoxidation of cytoplasmic reducing equivalents in Ehrlich ascites tumor cells. Galeotti T, Azzi A, Chance B. Biochim Biophys Acta; 1970 Jan 13; 197(1):11-24. PubMed ID: 5412032 [No Abstract] [Full Text] [Related]
14. Effects of sensitizers on cell respiration: II. The effects of hypoxic cell sensitizers on oxygen utilization in cellular and chemical models. Greenstock CL, Biaglow JE, Durand RE. Br J Cancer Suppl; 1978 Jun 13; 3():11-5. PubMed ID: 277209 [Abstract] [Full Text] [Related]
15. Reduction of 4-nitroquinoline 1-oxide to 4-hydroxyaminoquinoline 1-oxide in lysates of cytomegalovirus-infected cells. Speelman DJ, Lund H, Culling A, Kittredge JS, Williams BJ, Albrecht T. J Gen Virol; 1983 Nov 13; 64 (Pt 11)():2511-5. PubMed ID: 6315869 [Abstract] [Full Text] [Related]
16. Macroautoradiographic assays of 14C-labeled 4-nitroquinoline 1-oxide in adult and fetal mice. Takahashi G, Kinoshita K, Yasuhira K. Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar 13; 11(1-2):86-90. PubMed ID: 100154 [No Abstract] [Full Text] [Related]
17. Induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide in adult and fetal mice. Lu LJ, Baxter JR, Wang MY, Harper BL, Tasaka F, Kohda K. Cancer Res; 1990 Oct 01; 50(19):6192-8. PubMed ID: 2119250 [Abstract] [Full Text] [Related]
18. [The effect of fast electrons and menadione on the structural-functional status of Ehrlich ascites carcinoma cells in the early periods following irradiation]. Seĭlanov AS. Radiobiologiia; 1989 Oct 01; 29(5):595-600. PubMed ID: 2587696 [Abstract] [Full Text] [Related]
19. Actions of 4-nitroquinoline 1-oxide on eucaryotic cells: molecular and cellular studies. Ikenaga M, Takebe H. Carcinog Compr Surv; 1981 Oct 01; 6():65-91. PubMed ID: 6786746 [No Abstract] [Full Text] [Related]
20. Excision of 4-nitroquinoline 1-oxide damage and transformed in mouse cells. Ikenaga M, Kakunaga T. Cancer Res; 1977 Oct 01; 37(10):3672-8. PubMed ID: 409486 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]